BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19064593)

  • 21. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: three-dimensional computed tomography plan evaluation.
    Cengiz M; Gürdalli S; Selek U; Yildiz F; Saglam Y; Ozyar E; Atahan IL
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):464-8. PubMed ID: 17768014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of ovoid separation with various applications of high-dose-rate-intracavitary radiotherapy in carcinoma of uterine cervix: a study from rural centre of Maharashtra, India.
    Jain VS; Singh KK; Umberkar RB; Sarje MB; Jain SM
    J Cancer Res Ther; 2010; 6(2):210-4. PubMed ID: 20622370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between DVH-based doses and ICRU point-based doses to the rectum and the bladder using CT-based high-dose rate brachytherapy to the cervix.
    Rangarajan R; Subramanian S; Gopalakrishnan K
    Med Dosim; 2018 Autumn; 43(3):276-283. PubMed ID: 29198390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques.
    Sun LM; Huang HY; Huang EY; Wang CJ; Ko SF; Lin H; Song JC
    Radiother Oncol; 2005 Oct; 77(1):77-82. PubMed ID: 15885826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 2D and 3D imaging and treatment planning for postoperative vaginal apex high-dose rate brachytherapy for endometrial cancer.
    Russo JK; Armeson KE; Richardson S
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e75-80. PubMed ID: 22330985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dosimetric comparison of two high-dose-rate brachytherapy planning systems in cervix cancer: standardized template planning vs. computerized treatment planning.
    Patone H; Souhami L; Parker W; Evans M; Duclos M; Portelance L
    Brachytherapy; 2008; 7(3):254-9. PubMed ID: 18579447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
    Lee KC; Kim TH; Choi JH; Choi MS; Kim CY; Kim JY
    Yonsei Med J; 2004 Feb; 45(1):113-22. PubMed ID: 15004877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bladder-rectum spacer balloon in high-dose-rate brachytherapy in cervix carcinoma.
    Rai B; Patel FD; Chakraborty S; Sharma SC; Kapoor R; Aprem AS
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e217-22. PubMed ID: 23517809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective study of bladder morbidity in patients receiving intracavitary brachytherapy as all or part of their treatment for cervix cancer.
    Wilkinson JM; Harris MA; Davidson SE; Welch RS; Hunter RD; Swindell R
    Br J Radiol; 2003 Dec; 76(912):897-903. PubMed ID: 14711778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Megavoltage computed tomography image-based low-dose rate intracavitary brachytherapy planning for cervical carcinoma.
    Wagner TH; Langen KM; Meeks SL; Willoughby TR; Zeidan OA; Staton RJ; Shah AP; Manon RR; Kupelian PA
    Technol Cancer Res Treat; 2009 Apr; 8(2):123-30. PubMed ID: 19334793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geometric and dosimetric variations of ICRU bladder and rectum reference points in vaginal cuff brachytherapy using ovoids.
    Garipagaoglu M; Tuncel N; Köseoglu FG; Gülkesen H; Kizildag AU; Toy A; Dalmaz MG
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1607-15. PubMed ID: 15050342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point.
    Wachter-Gerstner N; Wachter S; Reinstadler E; Fellner C; Knocke TH; Wambersie A; Pötter R
    Radiother Oncol; 2003 Sep; 68(3):269-76. PubMed ID: 13129634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimizing urinary bladder radiation dose during brachytherapy for carcinoma of the cervix using balloon inflation technique.
    Malaker K; Shukla V; D'Souza H; Weatherburn H
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):257-66. PubMed ID: 15629619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dosimetric impact of heterogeneity corrections in high-dose-rate ¹⁹²Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans.
    Hyer DE; Sheybani A; Jacobson GM; Kim Y
    Brachytherapy; 2012; 11(6):515-20. PubMed ID: 22386723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A modified technique for high-dose-rate intracavitary brachytherapy in advanced cancer of the cervix.
    Sharma V; Mahantshetty U; Menon V; Sharma D
    Brachytherapy; 2003; 2(4):246-8. PubMed ID: 15062133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.